Predictors of survival in glioblastoma patients treated with fotemustine at first relapse after Stupp regimen: Analysis of GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology)

被引：0
|
作者：
Lombardi, G. [1 ]
Scoccianti, S. [2 ]
Fabrini, M. G. [3 ]
Santoni, M. [4 ]
Villani, V. [5 ]
Silvani, A. [6 ]
Marinelli, A. [7 ]
Lolli, I. [8 ]
Balducci, M. [9 ]
Arcicasa, M. [10 ]
Salvati, M. [11 ]
Sponghini, A. [12 ]
Vallarelli, S. [13 ]
Caroli, M. [14 ]
Imbesi, F. [15 ]
Bilancia, D. [16 ]
Faedi, M. [17 ]
Zagonel, V. [1 ]
Soffietti, R. [18 ,19 ]
Ruda, R. [18 ,19 ]
机构：
[1] Veneto Inst Oncol IRCCS, Dept Expt & Clin Oncol, Med Oncol 1, Padua, Italy
[2] AOU Careggi, Radiotherapy, Florence, Italy
[3] Azienda Osped Univ Pisana, Radiotherapy, Pisa, Italy
[4] Polytechinc Univ Marche Reg, Azienda Osped Univ, Med Oncol, Ancona, Italy
[5] Regina Elena Inst Canc Res, Neurooncol Unit, Rome, Italy
[6] Carlo Besta, Neurol, Milan, Italy
[7] Policlin Univ, Naples, Italy
[8] Saverio Bellis, Med Oncol, Castellana Grotte, Italy
[9] Catholic Univ Sacred Hearth, Radiat Oncol, Rome, Italy
[10] CRO Hosp, Radiotherapy, Aviano, Italy
[11] Hosp Rome, Umberto 1, Rome, Italy
[12] AOU Maggiore Carita, Dipartimento Oncol, Novara, Italy
[13] Azienda Osped, Policlin Bari, Bari, Italy
[14] Univ Milan, Neurosurg, Milan, Italy
[15] Osped Niguarda Ca Granda, Milan, Italy
[16] Azienda Osped, Reg San Carlo, Potenza, Italy
[17] Ist Sci Romagnolo Studio Cura Tumori IRST, Meldola, Italy
[18] Univ Turin, Turin, Italy
[19] City Hlth & Sci, Dept Neurooncol, Turin, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(15)30054-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2900
引用
收藏
页码：S584 / S584
页数：1
相关论文
共 29 条
  • [21] SURVIVAL IMPROVEMENT IN PATIENTS WITH GLIOBLASTOMA MULTIFORME TREATED AT A SPECIALIZED NEURO-ONCOLOGY OUTPATIENT CENTER VERSUS A GENERAL ONCOLOGY OUTPATIENT CENTER
    Schlimper, Claudia
    Schlag, Holger
    Weber, Friedrich
    NEURO-ONCOLOGY, 2012, 14 : 155 - 155
  • [22] Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO)
    Padovan, Marta
    Eoli, Marica
    Pellerino, Alessia
    Rizzato, Simona
    Caserta, Claudia
    Simonelli, Matteo
    Michiara, Maria
    Caccese, Mario
    Anghileri, Elena
    Cerretti, Giulia
    Ruda, Roberta
    Zagonel, Vittorina
    Lombardi, Giuseppe
    CANCERS, 2021, 13 (11)
  • [23] Depatuxizumab mafodotin (Depatux-M) plus temozolomide (TMZ) in recurrent glioblastoma patients: Real-world experience from a multicenter study of Italian Association of Neuro-Oncology (AINO).
    Caccese, Mario
    Padovan, Marta
    Eoli, Marica
    Pellerino, Alessia
    Rizzato, Simona
    Caserta, Claudia
    Simonelli, Matteo
    Michiara, Maria
    Zagonel, Vittorina
    Ruda, Roberta
    Lombardi, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] IMPROVED SURVIVAL OF GLIOBLASTOMA PATIENTS IN THE MODERN ERA: FIRST RESULTS FROM A MULTICENTER PROSPECTIVE REGISTRY - THE PROJECT OF THE EMILIA-ROMAGNA REGION IN NEURO-ONCOLOGY (PERNO)
    Brandes, A. A.
    Depenni, R.
    Marcello, N.
    Valentini, A.
    Faedi, M.
    Urbini, B.
    Crisi, G.
    Franceschi, E.
    Poggi, R.
    Baruzzi, A.
    NEURO-ONCOLOGY, 2012, 14 : 53 - 53
  • [25] Relation between residual tumor volume after surgery and overall survival in patients with glioblastoma - a single neuro-oncology center study
    Halaj, M.
    Kalita, O.
    Slachta, M.
    Valosek, J.
    Burkot, O.
    Kourilova, P.
    Cechakova, E.
    Dolezel, M.
    Hrabos, D.
    Drabek, J.
    Kudlova, P.
    Hrabalek, L.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2024, 87 (01) : 53 - 60
  • [26] A Survival Analysis with Identification of Prognostic Factors in a Series of 110 Patients with Newly Diagnosed Glioblastoma Before and After Introduction of the Stupp Regimen: A Single-Center Observational Study
    Illic, Rosanda
    Somma, Teresa
    Savic, Dragan
    Frio, Federico
    Milicevic, Mihailo
    Solari, Domenico
    Nikitovic, Marina
    Lavrnic, Slobodan
    Raicevic, Savo
    Milosevic, Snezana
    Cavallo, Luigi Maria
    Cappabianca, Paolo
    Grujicic, Danica
    WORLD NEUROSURGERY, 2017, 104 : 581 - 588
  • [27] Patterns of Care and Survival in a Retrospective Analysis of 1059 Patients With Glioblastoma Multiforme Treated Between 2002 and 2007: A Multicenter Study by the Central Nervous System Study Group of Airo (Italian Association of Radiation Oncology)
    Scoccianti, Silvia
    Magrini, Stefano Maria
    Ricardi, Umberto
    Detti, Beatrice
    Buglione, Michela
    Sotti, Guido
    Krengli, Marco
    Maluta, Sergio
    Parisi, Salvatore
    Bertoni, Filippo
    Mantovani, Cristina
    Tombolini, Vincenzo
    De Renzis, Costantino
    Lioce, Marco
    Fatigante, Lucia
    Fusco, Vincenzo
    Muto, Paolo
    Berti, Franco
    Rubino, Giovanni
    Cipressi, Samantha
    Fariselli, Laura
    Lupattelli, Marco
    Santoni, Riccardo
    Pirtoli, Luigi
    Biti, Giampaolo
    NEUROSURGERY, 2010, 67 (02) : 446 - 458
  • [28] Outcome of glioblastoma multiforme 1996N004. An audit of 420 consecutive patients treated in a single institution. Is there evidence to support radical primary surgery, is survival influenced by a surgeon with a specialist interest in neuro-oncology
    Jellinek, DA
    David, L
    NEURO-ONCOLOGY, 2004, 6 (04) : 376 - 377
  • [29] Randomized phase IIb clinical trial of continuation or non-continuation with six cycles of temozolomide after the first six cycles of standard first-line treatment in patients with glioblastoma: A Spanish research group in neuro-oncology (GEINO) trial.
    Balana, Carmen
    Mesia Barroso, Carlos
    Del Barco Berron, Sonia
    Pineda Losada, Estela
    Munoz-Langa, Jose
    Estival, Anna
    De las Penas, Ramon
    Fuster, Jose
    Gil Gil, Miguel J.
    Miguel Navarro, L.
    Alonso, Miriam
    Herrero, Ana
    Vaz Salgado, Maria Angeles
    Peralta, Sergi
    Olier, Clara
    Perez-Segura, Pedro
    Covela Rua, Marta
    Carrato, Cristina
    Sanz, Carolina
    Manuel Sepulveda-Sanchez, Juan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
123